$1.46
2.01% day before yesterday
Nasdaq, Jun 06, 10:00 pm CET
ISIN
US44984F3029
Symbol
IVF

INVO Fertility Stock price

$1.46
-0.44 23.16% 1M
-8.63 85.53% 6M
-8.26 84.98% YTD
-7.78 84.20% 1Y
-900.94 99.84% 5Y
-4,391.50 99.97% 10Y
-3,070.54 99.95% 20Y
Nasdaq, Closing price Fri, Jun 06 2025
-0.03 2.01%
ISIN
US44984F3029
Symbol
IVF

Key metrics

Market capitalization $3.16m
Enterprise Value $8.78m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.33
P/S ratio (TTM) P/S ratio 0.48
P/B ratio (TTM) P/B ratio 0.15
Revenue growth (TTM) Revenue growth 55.06%
Revenue (TTM) Revenue $6.59m
EBIT (operating result TTM) EBIT $-9.13m
Free Cash Flow (TTM) Free Cash Flow $-6.41m
Cash position $840.00k
EPS (TTM) EPS $-18.10
P/E forward negative
P/S forward 0.45
EV/Sales forward 1.26
Short interest 0.05%
Show more

Is INVO Fertility a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

INVO Fertility Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast INVO Fertility:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast INVO Fertility:

Buy
100%

Financial data from INVO Fertility

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
6.59 6.59
55% 55%
100%
- Direct Costs 3.85 3.85
50% 50%
58%
2.74 2.74
62% 62%
42%
- Selling and Administrative Expenses 10 10
54% 54%
155%
- Research and Development Expense 0.75 0.75
733% 733%
11%
-8.20 -8.20
64% 64%
-124%
- Depreciation and Amortization 0.93 0.93
127% 127%
14%
EBIT (Operating Income) EBIT -9.13 -9.13
69% 69%
-139%
Net Profit -25 -25
255% 255%
-382%

In millions USD.

Don't miss a Thing! We will send you all news about INVO Fertility directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

INVO Fertility Stock News

Neutral
GlobeNewsWire
about one month ago
SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics, today confirmed it will begin trading under the new symbol “IVF” at the market open on April 28, 2025.
Neutral
GlobeNewsWire
about 2 months ago
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device
Neutral
GlobeNewsWire
3 months ago
SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, and a leading provider of in vitro fertilization (IVF) and in vivo Intravaginal Culture (“IVC”) fertility treatments, announced today that it w...

Company Profile

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.

Head office United States
CEO Steven Shum
Founded 2007
Website www.invobioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today